Prolactin, Inflammation, and Parkinson's Severity

Exclusion Criteria

• •Premenopausal female patients
• •Patients with secondary or atypical parkinsonism (e.g., drug-induced, vascular, atypical parkinsonian syndromes)
• •Known endocrine disorders affecting prolactin levels (e.g., prolactinoma, pituitary adenoma, hypothyroidism)
• •Use of medications known to alter prolactin secretion (e.g., antipsychotics, dopamine antagonists, estrogen therapy)
• •History of other neurodegenerative diseases (e.g., Alzheimer's, Huntington's)
• •Presence of active infection, chronic inflammatory disease, or malignancy
• •Severe renal, hepatic, or cardiac failure
• •Inability to provide informed consent